OKYO Pharma Limited (OKYO) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.
The consensus price target is $7.00, representing an upside of 324.2% from the current price $1.65.
Analysts estimate Earnings Per Share (EPS) of $-0.15 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-0.12 vs est $-0.15 (beat +20%). Analyst accuracy: 75%.
OKYO Stock — 12-Month Price Forecast
$7.00
▲ +324.24% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for OKYO Pharma Limited, the price target is $7.00.
The average price target represents a +324.24% change from the last price of $1.65.
OKYO Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to OKYO Pharma Limited in the past 3 months
EPS Estimates — OKYO
75%
Analyst Accuracy
Fair
1 year compared
Actual vs Estimate
2025
Actual –$0.12
vs Est –$0.15
▲ 25.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — OKYO
Revenue Trend
Analysts expect stable revenue going forward.
